Fact or fiction? COVID-19 myths and controversies

Article

An "info-demic" has muddied the waters of what is true and what is false about COVID-19. A new webinar from MJH Life Sciences can clinicians sort through fact and fiction.

The news about COVID-19 has been coming fast and seems to change some facet of the disease nearly every day. Unfortunately, some of that news is either false, like hydroxychloroquine is the cure for COVID-19, or the science catches up, such as children always have low-risk cases of COVID-19. The oversaturation of information has been another epidemic running alongside the pandemic.

To combat this “info-demic,” the MJH Life Science’s COVID-19 Coalition is presenting the “Fact or Fiction? COVID-19 Myths and Controversies” webinar on September 29, 2020, at 6 PM, eastern. The webinar will be moderated by Saskia V. Popescu, PhD, MPH, MA, CIC, a term assistant professor at George Mason University and an adjunct professor at the University of Arizona College of Public Health. She will be joined by Angela Rasmussen, PhD, an associate research scientist at the Columbia University Mailman School of Public Health, as well as Emily Ricotta, PhD, MSc, a research fellow in the Epidemiology Unit, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health.

To register for webinar, click here.

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Recent Videos
Potential downstream benefits of RSV preventive measures, with Octavio Ramilo, MD
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Staphylococcus aureus risk in infants and neonatologist considerations with Aaron Milstone, MD
Octavio Ramilo, MD, reacts to the FDA approval of clesrovimab for RSV prevention | Image Credit: St. Jude Children's Research Hospital
Tina Tan, MD, comments on FDA expanded approval for MenQuadfi meningococcal disease vaccine
Tina Tan, MD, discusses impact of FDA's stricter COVID-19 vaccine policy for children
Related Content
© 2025 MJH Life Sciences

All rights reserved.